We specialize in hard to find items
All Categories
The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines
Share Tweet
*Price and Stocks may change without prior notice
*Packaging of actual item may differ from photo shown
- Electrical items MAY be 110 volts.
- 7 Day Return Policy
- All products are genuine and original
About The Great American Drug Deal: A New Prescription
Product Description Developing life-changing drugs is risky and expensive—but that’s not what makes them unaffordable.Drug pricing is a staple of every news cycle and political debate. And while we’ve struggled for decades to agree on solutions that serve all patients without jeopardizing the invention of new medicines, many Americans suffer because they can’t afford the drugs they need.Do we really have to choose between affordability and innovation?In The Great American Drug Deal, scientist and industry expert Peter Kolchinsky answers this question with a decisive No. The pharmaceutical industry’s commitment to creating new lifesaving drugs destined to become inexpensive generics can be balanced by the healthcare system’s commitment to making those drugs affordable for all patients—a Biotech Social Contract. Through deep research and compelling stories of breakthroughs and breakdowns, Kolchinsky presents solutions for striking a balance that are bold yet realistic and tackle today’s most pressing questions, including: Why doesn’t insurance make drugs affordable? How can we prevent price-jacking of older drugs? Why are drugs more expensive in America than elsewhere? How can we guarantee that all medicines eventually go generic so they are only temporarily expensive? What systemic failures led to the opioid crisis, and how can we prevent the next one? The Great American Drug Deal offers clear-eyed scrutiny of all players in the industry and examines vital ideas for closing loopholes, encouraging investment, dealing with bad actors, and educating consumers. It’s time we resolve to support patients and fuel discoveries that ease suffering now and for generations to come. Review "Magnificent. Compelling. Authoritative. Every member of Congress, staffer, and researcher interested in understanding the nexus of biomedical innovation, pricing, and affordability should read The Great American Drug Deal. Kolchinsky will amaze you with his knowledge of the industry and surprise you with his unshrinking prescriptions for reform. Clear and accessible, this is the history, science, and finance class that can help American voters steer the healthcare debate." --Amitabh Chandra, PhD Ethel Zimmerman Wiener Professor, Harvard Kennedy School of Government; Henry and Allison McCance Family Professor of Business Administration, Harvard Business School "This book is not only a superb piece of scholarship, but a veritable tutorial on the background (1980-2020) of US drug pricing policies and practices, as well as those of the payers/health insurance industry. The book comes across as a common-sense, temperate manifesto on how biopharma enterprises can not only shape the future debate on drug pricing and health insurance/policy but also offers thoughtful remedies and perspectives. Kolchinsky's command of the material is superb. I liked the book's style - serious while at the same time digestible and almost colloquial in places. Notions such as a 'Public Domain Day' and 'Price-Jacking' were beautiful, delicious. So too was the book's repetitive illustration of the 'generic drug mountain.' Excellent." --John Hawkins Author, Conscience and Courage: How Visionary CEO Henri Termeer Built a Biotech Giant and Pioneered the Rare Disease Industry "We are living in one of the most exciting periods of scientific innovation and drug discovery in history. Peter Kolchinsky steps past the headlines and simple rhetoric to take on directly the most challenging questions we face as a society in balancing the trade-offs between incentivizing and enabling the discovery of breakthrough medicines, and the responsibility we have in ensuring this is done in a sustainable way. This analysis elevates the discussion and offers new important thinking and actionable solutions that would benefit all stakeholders." --Michel Vounatsos, Chief Executive Officer, Biogen "What are we getting for what we spend in health care, and why? Read this book, which explains the
